KATIE ORTMAN: Open Payments
NPI 1285267732 · BROOKFIELD, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,062 in 45 payments from 12 companies in 2025. Trend: 2023 $363 · 2024 $1,060 · 2025 $1,062
Food & beverage: $1,062
| Company | Payments | Amount |
|---|---|---|
| HEARTFLOW, INC. | 6 | $211 |
| Alnylam Pharmaceuticals Inc. | 8 | $194 |
| PFIZER INC. | 5 | $127 |
| Abbott Laboratories | 5 | $112 |
| E.R. Squibb & Sons, L.L.C. | 5 | $94 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| Novartis Pharmaceuticals Corporation | 3 | $55 |
| Novo Nordisk Inc | 2 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| Amgen Inc. | 2 | $38 |
Products named: FFRct, ONPATTRO, VYNDAQEL, CARDIOMEMS, ELIQUIS, LEQVIO, Wegovy, Kerendia.
Industry payments across WI — which companies pay providers there.
